We are live on
!
Find out more
Vir Biotechnology
119 hedge funds and large institutions have $2.41B invested in Vir Biotechnology in 2020 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 48 increasing their positions, 22 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
118% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 22
26% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 27
9.73% more ownership
Funds ownership: 45.4% → 55.14% (+9.7%)
10% more capital invested
Capital invested by funds: $2.19B → $2.41B (+$213M)
6% more funds holding
Funds holding: 112 → 119 (+7)
2% more call options, than puts
Call options by funds: $5.68M | Put options by funds: $5.6M
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Holders
119
Holders Change
+7
Holders Change %
+6.25%
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.06%
New
34
Increased
48
Reduced
22
Closed
27
Calls
$5.68M
Puts
$5.6M
Net Calls
+$85K
Net Calls Change
+$367K
Top Buyers
| 1 |
Capital International Investors
Los Angeles,
California
|
+$439M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$223M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.6M |
| 4 |
Charles Schwab
San Francisco,
California
|
+$18.8M |
| 5 |
Goldman Sachs
New York
|
+$14M |
Top Sellers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
-$38.9M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$25.4M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$7.47M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$5.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$4.04M |
